Loading...

Abbott Laboratories (NYSE:ABT)

109.45 USD +3.24 USD ( +3.05% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

Profitability Summary

62/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Revenue
Abbott Laboratories
44.5B
Growth Rates
1 Year
19%
3 Years
13%
5 Years
15%
Operating Income
Abbott Laboratories
9.5B
Growth Rates
1 Year
40%
3 Years
35%
5 Years
31%
Net Income
Abbott Laboratories
7.7B
Growth Rates
1 Year
35%
3 Years
43%
5 Years
39%

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Gross Margin
Abbott Laboratories
57%
Operating Margin
Abbott Laboratories
21%
Net Margin
Abbott Laboratories
17%

ABT Earnings Waterfall
Abbott Laboratories

Revenue
44.5B USD
Cost of Revenue
-19.1B USD
Gross Profit
25.4B USD
Operating Expenses
-16B USD
Operating Income
9.5B USD
Other Expenses
-1.7B USD
Net Income
7.7B USD

Margins Comparison
Abbott Laboratories Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Abbott Laboratories
NYSE:ABT
193B USD
57%
21%
17%
IE
Medtronic PLC
NYSE:MDT
120B USD
69%
22%
16%
US
Stryker Corp
NYSE:SYK
77.3B USD
63%
19%
12%
US
Intuitive Surgical Inc
NASDAQ:ISRG
75.3B USD
69%
31%
28%
US
Becton Dickinson and Co
NYSE:BDX
71.5B USD
46%
14%
10%
US
Edwards Lifesciences Corp
NYSE:EW
60.3B USD
77%
33%
29%
Country US
Market Cap 193B USD
Gross Margin
57%
Operating Margin
21%
Net Margin
17%
Country IE
Market Cap 120B USD
Gross Margin
69%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 77.3B USD
Gross Margin
63%
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 75.3B USD
Gross Margin
69%
Operating Margin
31%
Net Margin
28%
Country US
Market Cap 71.5B USD
Gross Margin
46%
Operating Margin
14%
Net Margin
10%
Country US
Market Cap 60.3B USD
Gross Margin
77%
Operating Margin
33%
Net Margin
29%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

ROE
Abbott Laboratories
22%
ROA
Abbott Laboratories
10%
ROCE
Abbott Laboratories
15%
ROIC
Abbott Laboratories
13%

Return on Capital Comparison
Abbott Laboratories Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Abbott Laboratories
NYSE:ABT
193B USD
22%
10%
15%
13%
IE
Medtronic PLC
NYSE:MDT
120B USD
10%
5%
8%
8%
US
Stryker Corp
NYSE:SYK
77.3B USD
14%
6%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
75.3B USD
15%
13%
16%
27%
US
Becton Dickinson and Co
NYSE:BDX
71.5B USD
8%
4%
6%
5%
US
Edwards Lifesciences Corp
NYSE:EW
60.3B USD
29%
20%
25%
25%
Country US
Market Cap 193B USD
ROE
22%
ROA
10%
ROCE
15%
ROIC
13%
Country IE
Market Cap 120B USD
ROE
10%
ROA
5%
ROCE
8%
ROIC
8%
Country US
Market Cap 77.3B USD
ROE
14%
ROA
6%
ROCE
11%
ROIC
9%
Country US
Market Cap 75.3B USD
ROE
15%
ROA
13%
ROCE
16%
ROIC
27%
Country US
Market Cap 71.5B USD
ROE
8%
ROA
4%
ROCE
6%
ROIC
5%
Country US
Market Cap 60.3B USD
ROE
29%
ROA
20%
ROCE
25%
ROIC
25%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Operating Cash Flow
Abbott Laboratories
10.5B
Growth Rates
1 Year
7%
3 Years
21%
5 Years
22%
Capital Expenditures
Abbott Laboratories
-1.9B
Growth Rates
1 Year
-15%
3 Years
9%
5 Years
10%
Free Cash Flow
Abbott Laboratories
8.6B
Growth Rates
1 Year
14%
3 Years
25%
5 Years
26%

See Also

Similar Stocks
Time Machine